Ignite Creation Date:
2024-05-05 @ 4:49 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00328640
Status:
COMPLETED
Last Update Posted:
2007-04-27
First Post:
2006-05-18
Brief Title:
Quality Improvement in Stroke Prevention QUISP
Sponsor:
University of California San Francisco
Organization:
University of California San Francisco
Study Overview
Official Title:
Secondary Prevention After Ischemic Stroke A Trial of an Evidence-Based System-Wide Intervention
Status:
COMPLETED
Status Verified Date:
2007-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Is a secondary prevention intervention focused on implementation of standardized pre-printed discharge orders for hospitalists effective at increasing utilization of the following evidence-based treatments 6 months after discharge for ischemic stroke
1 Treatment with statins
2 Control of hypertension and
3 Anticoagulation in patients with atrial fibrillation
1 Treatment with statins
2 Control of hypertension and
3 Anticoagulation in patients with atrial fibrillation
Detailed Description:
There are several proven strategies for prevention of recurrent ischemic stroke including use of statins treatment of hypertension and anticoagulation in patients with atrial fibrillation Preliminary analyses suggest that only 9-15 of Kaiser Permanente Northern Californias ischemic stroke patients receive optimal care for secondary prevention of stroke The purpose of this study is to determine whether or not a quality improvement QI intervention can improve the care received by stroke patients This project consists of a randomized trial of standardized stroke discharge order forms to improve adherence with best practices in secondary stroke prevention The primary research question is Is a secondary prevention intervention focused on implementation of standardized pre-printed discharge orders for hospitalists effective at increasing utilization of the following evidence-based treatments 6 months after discharge for ischemic stroke 1 treatment with statins 2 control of hypertension and 3 anticoagulation in patients with atrial fibrillation
The primary outcome will be the proportion of patients receiving optimal treatment as defined by these three goals The impact of the intervention will be measures as a change after-to-before at intervention hospitals compared to non-intervention control hospitals with the institution as the unit of analysis Secondary analyses will evaluate the impact of the intervention on each of these components and on 6-month and 1-year rates of mortality readmission for stroke and costs of care after discharge
The primary outcome will be the proportion of patients receiving optimal treatment as defined by these three goals The impact of the intervention will be measures as a change after-to-before at intervention hospitals compared to non-intervention control hospitals with the institution as the unit of analysis Secondary analyses will evaluate the impact of the intervention on each of these components and on 6-month and 1-year rates of mortality readmission for stroke and costs of care after discharge
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None